user avatar
Edwards TAVR
@Edwards_TAVR
Driven by clinical evidence to improve outcomes for structural heart patients globally. This page is intended for U.S. healthcare professionals.
United States
heartvalves.com
Joined July 2019
87
Following
3,063
Followers
Posts
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Jan 28, 2021
    As the only valve approved for aortic THV-in-THV,* Edwards #SAPIEN3 #TAVR can be used to take control for the future of your patients. Learn about the #SAPIEN3Ultra valve, designed to meet your Higher Standard. info.edwards.com/rs/769-NOZ-917… #cardioTwitter #hearthealth #medEd
    00:00
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Jan 26, 2021
    Now indicated to treat high or greater surgical risk patients with aortic THV-in-THV, Edwards #SAPIEN3 #TAVR allows you to take control for the future of your patients. Learn about achieving your Higher Standard with the #SAPIEN3 Ultra valve. info.edwards.com/rs/769-NOZ-917… #heartnews
    00:00
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Aug 16, 2019
    #SAPIEN3 #TAVR is now approved for treatment of severe symptomatic #aorticstenosis in low-risk patients. Learn more at ow.ly/MR7h50vzSav
    00:00
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Sep 11, 2021
    Learn how the Edwards #SAPIEN3Ultra valve facilitates future coronary access so you can preserve your #TAVR patients' future treatment options. ow.ly/72Gl50FTCMb #hearthealth #cardioTwitter #medEd #heartnews #medTwitter #cardioEd #patient #severeaorticstenosis
    00:00
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Jan 30, 2021
    The lifetime management of your #TAVR patients is increasingly important. That's your Higher Standard. Now approved to treat ≥ high surgical risk patients w/ aortic THV-in-THV, the Edwards #SAPIEN3Ultra valve can be used today & in the future. Learn more. ow.ly/sqMF50D10qA
    00:00
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Sep 26, 2019
    With the #LowRisk patient floodgates opening, what is your hospital's primary goal for optimizing the #CarePathway? #TAVR #EdwardsBenchmark #EdwardsLifesciences #TCT2019
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Jan 19, 2021
    You know how important it is to address your patients’ severe symptomatic #aortic #stenosis as soon as symptoms appear. More of them than you may think are now eligible for #TAVR. ow.ly/IeC850Da1kb
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Oct 23, 2020
    As shared during #TCT2020, elevated #echoderivedgradients for 20mm Edwards #SAPIEN3Ultra valves did not correlate to worsening mortality, QoL, NYHA class, or hospital readmission at 1 yr. Read the full abstract by Dr. Eng et al for details. #TAVR ow.ly/I0Ru50C01j9 #medEd
    00:00
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Feb 14, 2024
    Dear doctors—this #VALVEntinesDay, continue to show your patients how much you care by encouraging them to screen for #HeartValveDisease. It only takes a moment to send a Valventine’s Day card. Get started at BeMyValventine.com.
    151K
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Sep 13, 2022
    The next innovation in #TAVR is here. Introducing SAPIEN 3 Ultra RESILIA valve. Together, we’re taking TAVR further. Learn more at ow.ly/rYv350KHa8f #RESILIA #takingTAVRfurther #SAPIEN3UltraRESILIA #cardiovascular #cardiotwitter
    00:00
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Aug 28, 2021
    The valve you choose for first-time #TAVR can affect your patients' future treatment options. First-time TAVR with the Edwards #SAPIEN valve is associated with more favorable coronary access post-TAVR-in-TAVR. Find out more. ow.ly/72Gl50FTCMb #cardioTwitter #heartnews
    00:00
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Aug 18, 2019
    Welcome to the official Twitter handle for #EdwardsLifesciences #TAVR information. We're dedicated to delivering you helpful practice resources including our Edwards insights on the TAVR industry. Follow us for continued information.
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Oct 25, 2020
    Dr. Eng's #TCT2020 data show a mean gradient ≥20mmHg is not a predictor of mortality (1 yr). However, discharge moderate/severe PVL and pacemaker implants did lead to increased mortality (1yr, 63% & 25%, respectively). Read the abstract for more. #TAVR ow.ly/4D8P50BZZB2
    00:00
  • user avatar
    Edwards TAVR
    @Edwards_TAVR
    Sep 3, 2019
    #SAPIEN3 valves help facilitate future #coronaryaccess for your post #TAVR patients. #cardioEd
    00:00